4Federal Institute for Drugs and Medical Devices. Organisa- tion [ EB/OL ]. [ 2015 - 05 - 16 ]. http ://www. bfarm, de/ EN/BfArM/Org/_node.html.
5Medicines and Healthcare Products Regulatory Agency.Ser- vices and information [ EB/OL ]. [ 2015 - 05 - 20 ]. https :// gov. uk/government/organisations/medicines-and- health-care-products-regulatory-agency/services- information.
6European Medicines Agency. Committees, working parties and other groups [ EB/OL]. [ 2015-05-20 ] .http ://www. ema. europa, eu/ema/index, jsp? curl = pages/about _ us/general/general_content_O00217.jsp&mid =.
7PRIETO L, SPOONER A, HIDALGO-SIMON A, et al.Eva- luation of the effectiveness of risk minimization measures [ J ].Pharmacoepidemiol Drug Sof, 2012,21 (8) : 896- 899.
